134 related articles for article (PubMed ID: 3055976)
1. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients.
Becker DM; Chamberlain B; Swank R; Hegewald MG; Girardet R; Baughman KL; Kwiterovich PO; Pearson TA; Ettinger WH; Renlund D
Am J Med; 1988 Nov; 85(5):632-8. PubMed ID: 3055976
[TBL] [Abstract][Full Text] [Related]
2. Metabolic risk factors for atherosclerosis in heart transplant recipients.
Kemna MS; Valantine HA; Hunt SA; Schroeder JS; Chen YD; Reaven GM
Am Heart J; 1994 Jul; 128(1):68-72. PubMed ID: 8017286
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein and hepatic lipase activity and high-density lipoprotein subclasses after cardiac transplantation.
Superko HR; Haskell WL; Di Ricco CD
Am J Cardiol; 1990 Nov; 66(15):1131-4. PubMed ID: 2220641
[TBL] [Abstract][Full Text] [Related]
4. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
Sharma AK; Myers TA; Hunninghake DB; Matas AJ; Kashtan CE
Clin Transplant; 1994 Jun; 8(3 Pt 1):252-7. PubMed ID: 8061364
[TBL] [Abstract][Full Text] [Related]
5. The determinants of elevated total plasma cholesterol levels in cardiac transplant recipients administered low dose cyclosporine for immunosuppression.
Laufer G; Grablowitz V; Laczkovics A; Miholic J; Heinz G; Wollenek G; Schreiner W; Wolfram J; Wolner E
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):241-7. PubMed ID: 1495285
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
[TBL] [Abstract][Full Text] [Related]
7. Serum lipid abnormalities in pediatric liver transplant patients.
McDiarmid SV; Gornbein JA; Fortunat M; Saikali D; Vargas JH; Busuttil RW; Ament ME
Transplantation; 1992 Jan; 53(1):109-15. PubMed ID: 1733055
[TBL] [Abstract][Full Text] [Related]
8. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
Law YM; Yim R; Agatisa P; Boyle GJ; Miller SA; Lawrence K; Webber SA
J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419
[TBL] [Abstract][Full Text] [Related]
9. Renal function and lipid metabolism in pregnant renal transplant recipients.
Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients.
Penson MG; Winter WE; Fricker FJ; Harker K; Kahler DA; Kubilis PS; Schowengerdt KO
J Heart Lung Transplant; 1999 Jul; 18(7):707-13. PubMed ID: 10452348
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the development and progression of dyslipidemia after heart transplantation.
Akhlaghi F; Jackson CH; Parameshwar J; Sharples LD; Trull AK
Transplantation; 2002 Apr; 73(8):1258-64. PubMed ID: 11981418
[TBL] [Abstract][Full Text] [Related]
12. Hyperlipidemia after clinical heart transplantation.
Taylor DO; Thompson JA; Hastillo A; Barnhart G; Rider S; Lower RR; Hess ML
J Heart Transplant; 1989; 8(3):209-13; discussion 219-20. PubMed ID: 2661770
[TBL] [Abstract][Full Text] [Related]
13. Hyperlipidemia in children after heart transplantation.
Singh TP; Naftel DC; Webber S; Dupuis J; Chin C; Spicer R; Schowengerdt KO; Ring WS; Morrow WR;
J Heart Lung Transplant; 2006 Oct; 25(10):1199-205. PubMed ID: 17045932
[TBL] [Abstract][Full Text] [Related]
14. Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids.
Ettinger WH; Klinefelter HF; Kwiterovitch PO
Atherosclerosis; 1987 Feb; 63(2-3):167-72. PubMed ID: 3493784
[TBL] [Abstract][Full Text] [Related]
15. Low levels of high-density lipoprotein cholesterol are associated with vascular remodeling in cardiac transplant recipients.
Ambrose MS; DeNofrio D; Kuvin JT; Pandian NG; Karas RH; Patel AR
Transplant Proc; 2006 Nov; 38(9):3016-20. PubMed ID: 17112888
[TBL] [Abstract][Full Text] [Related]
16. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients.
Lake KD; Reutzel TJ; Pritzker MR; Jorgensen CR; Emery RW
J Heart Lung Transplant; 1993; 12(4):580-90. PubMed ID: 8369320
[TBL] [Abstract][Full Text] [Related]
17. Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.
Chhatrala R; Siddiqui MB; Stravitz RT; Driscoll C; Sanyal A; Sargeant C; Luketic V; Sharma A; Sterling R; Matherly S; Puri P; Siddiqui MS
Liver Transpl; 2015 May; 21(5):623-30. PubMed ID: 25762084
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients.
Chin C; Rosenthal D; Bernstein D
Pediatr Transplant; 2000 Aug; 4(3):193-9. PubMed ID: 10933319
[TBL] [Abstract][Full Text] [Related]
19. Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids.
Ettinger WH; Goldberg AP; Applebaum-Bowden D; Hazzard WR
Am J Med; 1987 Sep; 83(3):503-8. PubMed ID: 3661587
[TBL] [Abstract][Full Text] [Related]
20. Strategies for minimizing hyperlipidemia after cardiac transplantation.
Kirklin JK; Benza RL; Rayburn BK; McGiffin DC
Am J Cardiovasc Drugs; 2002; 2(6):377-87. PubMed ID: 14727953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
